Adenocarcinoma of the Prostate
Series: Clinical Practice in Urology;
- Publisher's listprice EUR 85.55
-
35 481 Ft (33 792 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 8% (cc. 2 838 Ft off)
- Discounted price 32 643 Ft (31 089 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
35 481 Ft
Availability
Out of print
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1st Edition.
- Publisher Springer Verlag
- Date of Publication 16 November 1987
- Number of Volumes 1 pieces, Book
- ISBN 9783540162032
- Binding Hardback
- No. of pages225 pages
- Size 0x0 mm
- Weight 620 g
- Language English 0
Categories
Long description:
Carcinoma of the prostate increasingly dominates the attention of urologists for both scientific and clinical reasons. The search for an explanation and the prediction of the variable behaviour of the malignant prostatic cell continues unabated. The search for more precise tumour staging and more effective treatment is equally vigorous. Editors Andrew Bruce and John Trachtenberg have assembled acknowledged leaders in prostate cancer to present those areas of direct interest to the clinician. There are a number of other topics that might have been considered but most of these, such as experimental tumour models or biochemical factors affecting cell growth, still lack immediate application for the clinician. Carcinoma of the prostate continues to have its highest incidence in the western world, and the difference in comparison with the incidence in the Far East appears to be real and not masked by diagnostic or other factors. A number of other epidemiological aspects need careful analysis: Is the incidence increasing? Is the survival improving? Is the prognosis worse in the younger patient? Epidemiological data are easily misused and misinterpreted so that a precise analysis of the known facts makes an important opening chapter to this book.
Carcinoma of the prostate increasingly dominates the attention of urologists for both scientific and clinical reasons. The search for an explanation and the prediction of the variable behaviour of the malignant prostatic cell continues unabated. The search for more precise tumour staging and more effective treatment is equally vigorous. Editors Andrew Bruce and John Trachtenberg have assembled acknowledged leaders in prostate cancer to present those areas of direct interest to the clinician. There are a number of other topics that might have been considered but most of these, such as experimental tumour models or biochemical factors affecting cell growth, still lack immediate application for the clinician. Carcinoma of the prostate continues to have its highest incidence in the western world, and the difference in comparison with the incidence in the Far East appears to be real and not masked by diagnostic or other factors. A number of other epidemiological aspects need careful analysis: Is the incidence increasing? Is the survival improving? Is the prognosis worse in the younger patient? Epidemiological data are easily misused and misinterpreted so that a precise analysis of the known facts makes an important opening chapter to this book.
Table of Contents:
1 Epidemiology.- 2 Grading of Prostatic Carcinomas?Current Status.- 3 Tumor Markers in Prostatic Disease.- 4 Hormone Receptors in Prostatic Cancer.- 5 Imaging Techniques in the Diagnosis and Pelvic Staging of Prostatic Cancer.- 6 Update in Staging Systems.- 7 Pelvic Lymph Nodes: Diagnosis and Significance.- 8 Management of Localized Adenocarcinoma of the Prostate.- 9 Interstitial Radiotherapy.- 10 The Case for External Beam Radiotherapy of Certain Adenocarcinomas of the Prostate.- 11 Hormonal Therapy in Metastatic Prostatic Cancer.- 12 Chemotherapy of Prostatic Cancer.- 13 Clinical Trials in Prostatic Cancer: Methodology and Controversies.
More
Adenocarcinoma of the Prostate
35 481 HUF
32 643 HUF
Ovarian Cell Interactions: Genes to Physiology
35 481 HUF
31 224 HUF
Oxford Textbook of Palliative Nursing
51 358 HUF
46 222 HUF
